PTBP1 and Parkinson disease: Not surprisingly, an independent study using CRISPR/CasRx to suppress PTBP1 reported a similar time-course-dependent generation of dopaminergic neurons and demonstrated similar alleviation of motor deficits in the 6-OHDA PD mouse model [27].